Analysis identifies chemical constituents in Tropaeolum majus extract and assesses cytotoxicity in MDA-MB-231 cells, suggesting limited anticancer effects.
Objectives: The aim of this study was to analyze the chemical components present in the petroleum ether extract of Tropaeolum majus leaves using gas chromatography–mass spectrometry (GC-MS), and to assess its cytotoxic effects on the MDA-MB-231 human breast cancer cell line. Methods: Petroleum ether extract was obtained from shade-dried leaves of T. majus through Soxhlet extraction and analyzed by GC-MS to identify its lipophilic constituents. The cytotoxic potential of the extract was evaluated on MDA-MB-231 cells using the WST-1 assay across a concentration range of 0.01–100 μg/mL. Results: The GC-MS analysis identified various chemical constituents, including fatty acids, fatty alcohols, and diterpenoids, with hexadecanoic acid and isophytol being predominant. According to the WST-1 assay, the extract exhibited minimal cytotoxicity toward MDA-MB-231 cells, as cell viability remained above 86% even at the maximum tested concentration of 100 μg/mL. Conclusion: The petroleum ether extract of T. majus leaves was found to contain several bioactive lipophilic constituents; however, it did not demonstrate notable cytotoxic effects against MDA-MB-231 breast cancer cells at the concentrations tested. Additional research involving higher doses or different extract fractions is suggested to better assess its potential anticancer properties.
No takes yet. Share an insight, caveat, or question.
Shakir et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: